文献速递淋巴瘤

基线FDG PET/CT影像组学参数联合评分在原发纵隔B细胞淋巴瘤中的预后价值

Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.
PubMed 文献 · Blood Adv · 2026-01-01

本研究基于LYSA多中心队列180例初治PMBL患者,评估基线PET/CT影像组学参数的预后价值。TMTV、Dmax和medPCD与生存显著相关,三参数复合评分独立预测OS(HR 7.76,95%CI 1.59-37.74),优于传统临床风险因素,但需前瞻性外部验证。

要点

  • 基线PET/CT影像组学参数可提供PMBL独立预后信息。
  • 三参数复合评分(2-3个高危特征)独立预测OS,HR 7.76。
  • 复合评分优于传统临床风险因素,识别高危亚组。

核心结论

  • 基线PET/CT影像组学特征反映肿瘤负荷、空间离散度和紧凑度,在PMBL中提供独立预后信息。
  • 三参数影像组学评分优于传统风险因素,可识别诊断时的高危亚组,但临床实施前需前瞻性外部验证。

研究设计与样本

  • 事后分析纳入LYSA多中心队列2007-2017年180例初治PMBL患者,均接受标准免疫化疗。
  • 采用Kaplan-Meier和Cox回归分析PFS和OS。

主要发现

  • 识别出四类相关特征集群:活性、肿瘤负荷、巨大/碎片化和离散度。
  • TMTV和Dmax与较短PFS和OS显著相关,medPCD预测OS。
  • 校正IPI、巨块病变、B症状和治疗方案后,复合影像组学评分(2-3个高危特征 vs 0-1)独立预测OS(HR 7.76,95%CI 1.59-37.74),PFS呈强趋势。
  • 复合评分优于传统临床风险因素。

关键数值与推荐

  • 复合影像组学评分高危组(2-3个高危特征)对比低危组(0-1个)的OS风险比HR 7.76(95%CI 1.59-37.74)。

临床怎么用

  • 基线PET/CT影像组学参数可用于PMBL诊断时风险分层,识别高危患者。
  • 三参数复合评分可能辅助临床决策,但尚未推荐常规使用,需前瞻性外部验证。

局限性

  • 事后分析设计。
  • 需前瞻性和外部验证后方可临床实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary mediastinal B-cell lymphoma (PMBL) is an uncommon aggressive lymphoma with generally favorable outcomes; however, 15% to 20% of patients develop refractory disease. Reliable baseline prognostic biomarkers remain lacking. We evaluated the prognostic value of radiomic parameters derived from baseline 18F-fluorodeoxyglucose positron emission tomography (PET)/computed tomography in newly diagnosed PMBL. This post hoc analysis included 180 patients who were treatment naive from the multicenter Lymphoma Study Association (LYSA) cohort (2007-2017) treated with standard immunochemotherapy. Twelve 3-dimensional PET-derived radiomic features were extracted using Oncometer3D. Interparameter correlations were assessed using Spearman coefficients. Receiver operating characteristic analyses determined optimal cutoffs. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier estimates and Cox regression models. Four clusters of correlated features were identified: activity, tumor burden, massiveness/fragmentation, and dispersion. Among these, total metabolic tumor volume (TMTV), maximal interlesion distance (Dmax), and median peripheral centroid distance (medPCD) demonstrated the strongest prognostic associations. TMTV and Dmax were significantly associated with shorter PFS and OS, whereas medPCD predicted OS. In multivariable analysis adjusted for International Prognostic Index, bulky disease, B symptoms, and treatment regimen, a composite radiomic score (2-3 high-risk features vs 0-1) independently predicted OS (hazard ratio, 7.76 [95% confidence interval, 1.59-37.74]) and showed a strong trend for PFS. The composite score outperformed conventional clinical risk factors. Baseline PET-derived radiomic features capturing tumor burden, spatial dispersion, and compactness provide independent prognostic information in PMBL. A 3-parameter radiomic score outperformed conventional risk factors and identified a high-risk subgroup at diagnosis, warranting prospective and external validation before clinical implementation.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Decazes P, Rossi C, Sesques P, et al. Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma. Blood Adv. 2026. PMID: 42118857. doi:10.1182/bloodadvances.2026020168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。